Famotidine
- Product NDC
- 63323-739
- 11-digit product format
- 633230739
- Labeler code
- 63323
- Product ID
- 63323-739_241710d5-bcef-4852-a09c-0e681250e6aa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Famotidine
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA075813
- Marketing category
- ANDA
- Marketing start
- 2001-03-15
- Substance
- FAMOTIDINE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Famotidine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FAMOTIDINE | 10 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5QZO15J2Z8 |
| Rxcui | 1743833 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63323-739-16 | Famotidine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | | 7 |
| 63323-739-41 | Famotidine | 2 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 2 | | 7 |
| 63323-739-11 | Famotidine | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | | 6 |
| 63323-739-12 | Famotidine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | | 6 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| FAMOTIDINE | ACTIVE INGREDIENT | 5QZO15J2Z8 | FAMOTIDINE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| FAMOTIDINE | ACTIVE INGREDIENT | 5QZO15J2Z8 | FAMOTIDINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| FAMOTIDINE | ACTIVE MOIETY | 5QZO15J2Z8 | FAMOTIDINE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| FAMOTIDINE | ACTIVE MOIETY | 5QZO15J2Z8 | FAMOTIDINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| ASPARTIC ACID | INACTIVE INGREDIENT | 30KYC7MIAI | FAMOTIDINE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| ASPARTIC ACID | INACTIVE INGREDIENT | 30KYC7MIAI | FAMOTIDINE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | FAMOTIDINE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63323-739 | FAMOTIDINE (FAMOTIDINE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC
] | 7 | Current NDC, Legacy NDC, 2 package rows | 20210813_ce533636-cc9b-45d0-87a6-5390377ff28a.zip |
| 63323-739 | FAMOTIDINE (FAMOTIDINE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC
] | 6 | Current NDC, Legacy NDC, 2 package rows | 20221110_aeb27cea-1ff7-4a6e-93f1-d4c4dac5faa7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63323-739-11 | 63323073911 | 2 mL in 1 VIAL, SINGLE-DOSE | 2 ml | | | | | Historical |
| 63323-739-12 | 63323073912 | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-739-12) / 2 mL in 1 VIAL, SINGLE-DOSE (63323-739-11) | | 2001-03-15 | 0000-00-00 | No | No | Current |
| 63323-739-16 | 63323073916 | 25 VIAL, SINGLE-USE in 1 TRAY (63323-739-16) / 2 mL in 1 VIAL, SINGLE-USE (63323-739-41) | | 2001-03-15 | 0000-00-00 | No | No | Current |
| 63323-739-41 | 63323073941 | 2 mL in 1 VIAL, SINGLE-USE | 2 ml | | | | | Historical |